Cerebral ischemia induces a rapid suppression of spontaneous brain rhythms prior to major alterations in ionic homeostasis. It was found in vitro during ischemia that the rapidly formed adenosine, resulting from the intracellular breakdown of ATP, may inhibit synaptic transmission via the A 1 receptor subtype. The link between endogenous A 1 receptor activation during ischemia and the suppression of spontaneous electrocortical activity has not yet been established in the intact brain. The aim of this study was to investigate in vivo the effects of A 1 receptor antagonism by 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) on the time to electrocortical suppression during global cerebral ischemia. Adult male Wistar rats under chloral hydrate anesthesia were subjected to 1 minute transient "four-vessel occlusion" ischemic episodes, separated by 20 minutes reperfusion. The rats were injected intraperitoneally with either 1.25 mg/Kg DPCPX dissolved in 2 ml/Kg dimethyl sulfoxide (DMSO) or the same volume of DMSO alone, 15 minutes before the third ischemic episode.
Introduction
It has been recognized for a long time that cerebral ischemia induces a rapid suppression of spontaneous brain rhythms prior to major alterations in ionic homeostasis reflected by the anoxic depolarization (Leão 1947) . To date, the early factors responsible for the ischemic "shut-down" of the electrocortical activity remain poorly understood. During cerebral ischemia/hypoxia, the rapidly formed adenosine, resulting from the intracellular breakdown of ATP, was found to suppress electrically evoked synaptic transmission through the activation of A 1 receptor subtype (A 1 R) in the rat hippocampus in vitro (Fowler 1989; Fowler 1990; Gribkoff et al. 1990; Dale et al. 2000; Sebastião et al. 2000) and, more recently, in vivo (Gervitz et al. 2001; Fowler et al. 2003; Gervitz et al. 2003) . The possible link between endogenous A 1 R activation during ischemia and suppression of spontaneous electrocortical activity has not yet been established in the intact brain.
Global cerebral ischemia (GCI) in rat is followed by a rapid suppression of spontaneous electrocortical activity (Pulsinelli and Brierley 1979; Barzaghi et al. 1982; Zagrean et al. 1995) . In the rat brain, A 1 Rs were found with high densities on the large cortical pyramidal neurons (Rivkees et al. 1995) and in some thalamic neurons (Fastbom et al. 1987) , structures that are directly involved in the generation of spontaneous brain rhythms (reviewed in Steriade 2006) . Since a massive ischemic increase of interstitial adenosine was reported in the rat brain (Van Wylen et al. 1986 ), we hypothesize that ischemic A 1 R activation may contribute to the suppression of electrocortical activity.
We have recently developed a method to detect small changes in the time to electrocortical suppression (T ES ) (Ilie et al. 2006 ) during transient GCI episodes under anesthesia in rat (Moldovan et al. 2004b) . The aim of the present study was to investigate the Page 3 of 24 A 1 receptors accelerate ischemic ECoG suppression (JN-00466-2006 .R2) 4 effect of A 1 R antagonism on T ES. The xanthine derivative 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) is a very potent and selective antagonist for rat A 1 Rs (Bruns et al. 1987) . In vitro, DPCPX abolished the rapid depression of synaptic transmission that appeared during the exposure of hippocampal slices to hypoxia (Zeng et al. 1992; Canhão et al. 1994; Jin and Fredholm 1997; Coelho et al. 2000; Pearson et al. 2001) . Since DPCPX has a very good penetration into the rat brain (Baumgold et al. 1992) , we tested the in vivo the effect of systemically administered DPCPX on T ES during GCI.
Materials and methods

Animals and experimental procedures
The study was carried out in 15 adult male Wistar rats (200-300g) with free access to food and water. Surgical and experimental procedures were performed under chloral hydrate anesthesia (Sigma, 0.4 g/kg. i.p. maintained with 0.1 g/kg hourly) with external body temperature regulation.
Our model to investigate the ischemic electrocortical suppression was recently described in detail (Ilie et al. 2006) . Briefly, the rats were first implanted with two pairs of epidural electrodes for electrocorticographic (ECoG) recordings. After ~ 1 week, the rats were subjected to a second surgery to induce transient, non-lethal, GCI by the "four-vessel occlusion" model (Pulsinelli and Brierley 1979; Zagrean et al. 1995; Moldovan et al. 2004b) .
The animals were then left to recover overnight and subjected to another GCI episode. All rats were killed by cervical dislocation at the completion of experiments. The experiments were carried out with the approval of the local committee for animal research of "Carol Davila" University of Medicine and Pharmacy (Bucharest, Romania) in accordance with the American Physiological Society ethical policies and procedures regarding animal experimentation.
Pharmacological investigations
To account for individual variability (Pulsinelli and Brierley 1979) we tested 4 consecutive 1-minute GCIs, separated by 20 minutes reperfusion intervals (Ilie et al. 2006) . We used the first 2 GCIs to establish a baseline and then injected intraperitoneally DPCPX (Sigma) dissolved in dimethyl sulfoxide (DMSO, Sigma), 15 minutes (Baumgold et al. 1992; Bisserbe et al. 1992) prior to the 3 rd GCI. We investigated the 4 th GCI to test for peak effect and another GCI, ~ 15 hours after drug administration, to investigate recovery (Fig. 1) .
In rats, pharmacological effects of intraperitoneally administered DPCPX were obtained for concentrations as low as 0.1 mg/Kg (Simpson et al. 1992; Liu et al. 2006) , however, some DPCPX effects may require as high as 5 mg/Kg (Li and Roth 1999) . In order to ascertain a maximum effect we tested both 5 mg/Kg (n=5) and 1.25 mg/Kg DPCPX (n=5). DPCPX was dissolved in 2 ml /Kg DMSO, and the control group (n=5) received a similar volume of DMSO alone.
Electrophysiological signals and statistics
The ECoG signals from 2 bipolar occipito-frontal leads were recorded using a MP100 Biopac System (Biopac Systems Inc.) with EEG100A amplifiers (1-35Hz band-pass filter, -3 dB).
Simultaneously with ECoG, the electrocardiogram (ECG) was recorded from 2 Ag/AgCl electrodes attached to the forepaws using the same MP100 Biopac System. The heart rate (HR) was calculated off-line as previously described in detail (Moldovan et al. 2004a ).
We recently introduced an automatic method, to estimate T ES from ECoG during GCI (Ilie et al. 2006) . Briefly, the root mean square of the signal (RMS) (calculated on consecutive 1-second epochs) was filtered through a low-pass 3 rd order Butterworth filter using a zero-phase forward and reverse algorithm. The T ES was then calculated as the time between the clamping of the both common carotid arteries and the decay of the filtered signal below 30%.
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Signal processing was implemented in MATLAB (MathWorks Inc.). Numeric results are given as mean ± S.E.M. Nonparametric statistical comparisons were performed by Wilcoxon paired test (SPSS, SPSS Inc.).
Results
Our experimental setup allowed recording of large ECoG ( Fig. 1) and ECG (Fig. 2 ) signals.
During GCI there was a complete suppression of the electrocortical activity (Fig. 1 ). During each GCI we detected a slight (~ 25%) decrease in HR ( Fig. 2A ) which peaked after ~ 30 seconds ( Fig. 2B, C) . This ischemic sinusal bradycardia ( Fig. 2D , E) recovered spontaneously prior to reperfusion with a time course that was reproducible within the same experiment
The ECoG (Fig. 1A ) and ECG (data not shown) changes were unaffected by DMSO administration in control group. Prior to the GCI, DPCPX had also no apparent effect on either ECoG (Fig. 1B) , or ECG (Fig. 2) . During the GCI, DPCPX induced alterations easily recognizable in all investigated rats: ECoG suppression appeared delayed and interrupted by bursts of activity which could be observed up to the end of the investigated ischemia (Fig.   1B) . After 1.25 mg/Kg DPCPX, both ECoG (Fig. 1B) and ECG (Fig. 2 ) recovered fully after each GCI. Nevertheless, after 5 mg/Kg DPCPX reperfusion consistently led to malignant arrhythmias (data not shown) and the experiments had to be discontinued.
The automatic T ES quantification after DPCPX administration was complicated by the need to distinguish the prolonged persistence of "background" ECoG activity from the "first burst" (Fig. 1B) . We found that a 0.01 Hz RMS filter could reasonably predict visual T ES estimation both in control and DPCPX groups (Fig.1 ). The differences in T ES estimation between the two ECoG channels never exceeded 2 seconds. For consistency we considered (Fig. 1B, 3B ).
Discussion
We investigated the effect of systemic administration of the A 1 R antagonist DPCPX on the suppression of spontaneous electrocortical activity during transient global cerebral ischemia in rat. We found that DPCPX reversibly prolonged T ES . Consistent with previous in vitro observations from rat hippocampal slices (Fowler 1989; Fowler 1990; Canhão et al. 1994; Pearson et al. 2001) it is likely that DPCPX prevented the rapid synaptic depression caused by the ischemic release of adenosine (Van Wylen et al. 1986; Valtysson et al. 1998; Dale et al. 2000) . Thus, we report here the first evidence that ischemic activation of A 1 Rs observed in vitro contributes to the suppression of spontaneous ECoG activity recorded from the intact brain in vivo.
Ischemic suppression of spontaneous ECoG activity was found to occur within 15 seconds in various species including rats (Barzaghi et al. 1982; Ilie et al. 2006) , cats (Hossmann et al. 1990 ) and humans (de Vries et al. 1998) . The ultimate cause of the ischemic loss of ECoG activity is the wide spread anoxic depolarization resulting from the failure of The impairment in the ischemic ECoG suppression induced by DPCPX was easily identifiable at visual inspection (Fig. 1) . In addition to the prolonged persistence of the "background" ECoG activity, DPCPX revealed bursts of activity which could be observed up to the end of the investigated ischemia (Fig. 1B) . In this study we could not directly address whether the persistence of spontaneous ECoG activity and the bursting activity were the consequence of the same altered circuit. In fact, in vitro recordings may suggest that the early ischemic bursting activity may be purely neocortical (Fleidervish et al. 2001) . Therefore, we adjusted the quantification method (Fig. 3A) to measure T ES of only the "background" ECoG activity. While the simple filtered RMS decay may not be appropriate for detecting brief transients like "isolated" bursts, it could accurately distinguish the "first burst" from the suppression of the "background" ECoG activity (Fig. 1B, 3A) . Furthermore, the same filter settings could reasonably estimate T ES in control group (Fig. 1A) which ensured the consistency of the comparisons.
The rapid suppression of spontaneous ECoG activity following cerebral ischemia was proposed to be a neuroprotective response (Hossmann et al. 1990; Nagashima 1994) . During ischemia/hypoxia lethal neuronal injury occurs largely due to increased levels of glutamate
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A 1 receptors accelerate ischemic ECoG suppression (JN-00466-2006.R2) 9 and the subsequent activation of N-methyl-D-aspartate (NDMA) receptors (Simon et al. 1984) . In vitro, endogenous adenosine release was found to efficiently prevent glutamate release via presynaptic A 1 Rs (Hershkowitz et al. 1993; Coelho et al. 2000; Arrigoni et al. 2005 ). Furthermore, recovery of synaptic transmission in hippocampal slices subjected to prolonged ischemia was largely impaired after DPCPX (Sebastião et al. 2001) . We found that in vivo, DPCPX did not alter ECoG recovery after 1 minute GCI (Fig. 1B) . While in vitro A 1 R antagonists may slightly shorten the delay to anoxic depolarization (Lee and Lowenkopf 1993), several minutes of anoxic depolarization may be required to induce neuronal damage in the most ischemic-sensitive neurons (Sorimachi et al. 1999; Halaby et al. 2004) . Thus, it is unlikely that DPCPX induced a significant acute neuronal damage during the 1 minute transient ischemic episodes used in this study.
Consistent with a low basal adenosine tone (Fulga and Stone 1998) we found that DPCPX administration had no effect on the ECoG amplitude outside the GCI. Whereas cerebral A 1 Rs are primarily neuronal (Ochiishi et al. 1999 ), expression of A 1 Rs on several non-neuronal tissues, most notably in the heart (for review see Fredholm et al. 2001) , may confound the neuronal interpretation of T ES changes induced by systemically administered DPCPX. At doses of 1.25 mg/Kg we found that DPCPX prolonged T ES (Fig. 1, 3 ) without altering the basal HR (Fig. 2) . Furthermore, during "four-vessel occlusion" we detected a very slight sinusal bradycardia with a time-course that was unaffected by DPCPX (Fig. 2) .
The observed decrease in HR normalized before the onset of reperfusion, resembling the transient reflex hypoxic bradycardia (Giussani et al. 1993 ) that was also found to be unaffected by DPCPX (Koos and Maeda 2001). Therefore, we consider it unlikely that cardiovascular actions of DPCPX contributed to the prolongation of T ES reported here.
During our repeated ischemia paradigm we found that 5 mg/Kg DPCPX had no ECG effects prior to, or during the following 1 minute cerebral ischemia, however, it led to Page 9 of 24 A 1 receptors accelerate ischemic ECoG suppression (JN-00466-2006.R2) 10 malignant arrhythmias early during reperfusion. These cardiac effects were not detected at 1.25 mg/Kg DPCPX (Fig. 2) . Adenosine is a known modulator of ventricular automaticity (for review see Hernandez and Ribeiro 1995). We may speculate that the high concentrations of DPCPX impaired the anti R-adrenergic effect of adenosine and increased the ventricular vulnerability to fibrillation (Lubbe et al. 1978) . Further investigations should be carried out to explore this antiarrhythmogenic, potentially protective, role of A 1 Rs in the context of cerebral ischemia.
In spite of the differences in the cardiac response, T ES prolongation remained unchanged after as much as 4 times increase in DPCPX concentration (Fig. 2B) . We recently reported, on the same ischemic model, that under energy-stress conditions (such as those occurring during rapid repeated cerebral ischemia and kainate-induced seizures) T ES could be prolonged to a remarkably similar "plateau" (Ilie et al. 2006) . Consistent with the "depletable adenosine pool hypothesis" formulated in vitro (Pearson et al. 2001) , it is likely that the maximal T ES prolongation reflects the limit in the plasticity of adenosine release during ischemia (reviewed in Pearson et al. 2003) . Thus, our simple experimental model used to investigate changes in T ES may offer a new in vivo window into the ischemic adenosine release and its contribution to the electrical "shut-down" of the whole brain. 
